Ultralife Corporation
ULBI
$6.13
-$0.25-3.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.56% | 21.51% | 12.98% | 21.03% | -1.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.56% | 21.51% | 12.98% | 21.03% | -1.56% |
| Cost of Revenue | 9.54% | 24.95% | 17.57% | 24.57% | 0.32% |
| Gross Profit | 13.75% | 10.79% | 0.50% | 11.64% | -7.04% |
| SG&A Expenses | 33.04% | 22.35% | 21.97% | 20.63% | 41.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.39% | 25.18% | 18.13% | 24.56% | 7.56% |
| Operating Income | -1,240.88% | -146.91% | -38.40% | -11.79% | -103.75% |
| Income Before Tax | -2,161.82% | -596.03% | -71.06% | -32.19% | -84.10% |
| Income Tax Expenses | -1,150.76% | -781.08% | -71.51% | -19.35% | -0.38% |
| Earnings from Continuing Operations | -3,298.71% | -546.95% | -70.93% | -35.30% | -91.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 179.49% | 228.57% | 137.50% | -7.69% | -269.57% |
| Net Income | -3,925.77% | -572.87% | -70.39% | -35.49% | -93.25% |
| EBIT | -1,240.88% | -146.91% | -38.40% | -11.79% | -103.75% |
| EBITDA | -150.86% | -39.49% | -22.34% | -1.83% | -77.42% |
| EPS Basic | -3,909.40% | -572.90% | -70.54% | -36.42% | -93.34% |
| Normalized Basic EPS | -17.61% | -295.33% | -66.36% | -28.31% | -172.15% |
| EPS Diluted | -4,304.72% | -572.90% | -72.10% | -37.61% | -93.70% |
| Normalized Diluted EPS | -18.68% | -298.10% | -65.91% | -28.00% | -172.09% |
| Average Basic Shares Outstanding | 0.15% | 0.13% | 0.40% | 1.45% | 1.78% |
| Average Diluted Shares Outstanding | -0.64% | -1.35% | -1.00% | 0.98% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |